News & AnalysisCaris Life Science inks $830mCaris Life Sciences, a precision medicine platform, has secured $830 million in funding.ByIris Dorbian12 May 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs